Prospective observational study of MRI-guided radiotherapy

Status

Recruiting

Phases

Unknown

Study type

Observational

Source

DRKS

Registry ID

DRKS00039073

Enrollment

750

Registered

2026-01-23

Start date

2020-05-13

Completion date

Unknown

Last updated

2026-02-02

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Various treatment regions treated with the MR-Linac are being investigated, including the central nervous system (CNS), head and neck, thorax, breast, abdomen/pelvis, and extremities.

Interventions

Group 1: This prospective observational study aims to document and pseudonymously analyze the clinical outcomes of MRI-guided radiotherapy for quality control purposes. Systematic assessment of the to

Eligibility

Sex/Gender

All

Age

18 Years to No maximum

Inclusion criteria

Inclusion criteria: none

Exclusion criteria

Exclusion criteria: none

Design outcomes

Primary

Measure	Time frame
Regular follow-up examinations are conducted as clinically indicated and as required by law. The systematic collection of data will enable the long-term assessment of the effectiveness of MRI-guided radiotherapy for patients.	—

Countries

Germany

Contacts

Public ContactStefanie Corradini

Klinikum der LMU München

stefanie.corradini@med.uni-muenchen.de+4989440076763

Outcome results

None listed

Source: DRKS (via WHO ICTRP) · Data processed: Feb 7, 2026